Literature DB >> 6871652

Comparison of tetracycline and minocycline in the treatment of non-gonococcal urethritis.

J D Oriel, G L Ridgway.   

Abstract

The activity of tetracycline hydrochloride and minocycline hydrochloride was compared against 12 strains of Chlamydia trachomatis and Ureaplasma urealyticum; minocycline was more active in vitro against both organisms. A group of 145 men with non-gonococcal urethritis was treated for one week with either tetracycline hydrochloride 500 mg six hourly or minocycline 50 mg twice daily. The clinical results obtained were similar: 61 of 77 (79%) men treated with tetracycline and 53 of 68 (78%) men treated with minocycline were free from urethritis one to two weeks after completing treatment. Both antibiotics were clinically effective against C trachomatis, but activity against U urealyticum was less consistent. Side effects were noted in 14 (18%) men treated with tetracycline and eight (12%) men treated with minocycline; they were predominantly gastrointestinal.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6871652      PMCID: PMC1046193          DOI: 10.1136/sti.59.4.245

Source DB:  PubMed          Journal:  Br J Vener Dis        ISSN: 0007-134X


  7 in total

1.  Comparative susceptibility of anaerobic bacteria to minocycline, doxycycline, and tetracycline.

Authors:  A W Chow; V Patten; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1975-01       Impact factor: 5.191

2.  Activity of minocycline and tetracycline against respiratory pathogens related to blood levels.

Authors:  M J Wood; W Farrell; S Kattan; J D Williams
Journal:  J Antimicrob Chemother       Date:  1975-09       Impact factor: 5.790

3.  Tetracycline-resistant T-mycoplasmas (Ureaplasma urealyticum) from patients with a history of reproductive failure.

Authors:  M S Spaepen; R B Kundsin; H W Horne
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

4.  The incidence of tetracycline-resistant strains of Ureaplasma urealyticum.

Authors:  R T Evans; D Taylor-Robinson
Journal:  J Antimicrob Chemother       Date:  1978-01       Impact factor: 5.790

Review 5.  The genital mycoplasmas (first of two parts).

Authors:  D Taylor-Robinson; W M McCormack
Journal:  N Engl J Med       Date:  1980-05-01       Impact factor: 91.245

6.  Antimicrobial susceptibility of Ureaplasma urealyticum.

Authors:  J W Davis; B A Hanna
Journal:  J Clin Microbiol       Date:  1981-02       Impact factor: 5.948

7.  Prediction of efficacy of antimicrobial agents in treatment of infections due to Chlamydia trachomatis.

Authors:  W R Bowie; C K Lee; E R Alexander
Journal:  J Infect Dis       Date:  1978-11       Impact factor: 5.226

  7 in total
  3 in total

Review 1.  Chlamydia trachomatis in adolescents and adults. Clinical and economic implications.

Authors:  C A Marra; D M Patrick; R Reynolds; F Marra
Journal:  Pharmacoeconomics       Date:  1998-02       Impact factor: 4.981

2.  Periodic health examination, 1996 update: 2. Screening for chlamydial infections. Canadian Task Force on the Periodic Health Examination.

Authors:  H D Davies; E E Wang
Journal:  CMAJ       Date:  1996-06-01       Impact factor: 8.262

3.  In vitro activities of ofloxacin and four other new quinoline-carboxylic acids against Chlamydia trachomatis.

Authors:  A Nagayama; T Nakao; H Taen
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.